N.H. — March 14, 2019 – (NASDAQ: ICAD), a global medical technology leader providing
innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief
Executive Officer, and Stacey Stevens, Chief Strategy & Commercial Officer,
will be meeting with investors in a one-on-one format at the 31st Annual ROTH
Conference, being held March 17-19 in Laguna Niguel, California.
About iCAD, Inc.
Headquartered in Nashua, NH, iCAD is a
global medical technology leader providing innovative cancer detection and
therapy solutions. For more information, visit .
on behalf of iCAD, Inc.